Hiromi Muramatsu
California University of Pennsylvania(US)Edelman (United Kingdom)(GB)University of Pennsylvania(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, Virus-based gene therapy research, Immune Cell Function and Interaction
Most-Cited Works
- → Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability(2008)1,795 cited
- → Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes(2015)999 cited
- → Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination(2017)875 cited
- → Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA(2011)861 cited
- → Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses(2021)677 cited
- → Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation(2010)658 cited